Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Exsymol is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by a distinct examiner, SPAINE, ROBERT FRANKLIN, within a distinct art unit. This indicates a very narrow and specific focus for the company's current patent activities.
SPAINE, ROBERT FRANKLIN is the busiest examiner with 1 pending case, representing the total active volume of the portfolio. Because there is only the pending office action, the applicant's interaction is confined to the distinct art unit. This allows for a highly targeted approach to the examiner's specific requirements.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17908481 | PROCESS FOR PRODUCING A HYDROLYSATE OF SCUTELLARIA ROOT, WHICH IS ENRICHED AND STANDARDIZED WITH FLAVONOIDS OF INTEREST, THE HYDROLYSATE OBTAINED BY SUCH A PROCESS, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF SUCH A HYDROLYSATE | SPAINE, ROBERT FRANKLIN | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17908481 | PROCESS FOR PRODUCING A HYDROLYSATE OF SCUTELLARIA ROOT, WHICH IS ENRICHED AND STANDARDIZED WITH FLAVONOIDS OF INTEREST, THE HYDROLYSATE OBTAINED BY SUCH A PROCESS, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF SUCH A HYDROLYSATE | SPAINE, ROBERT FRANKLIN | 1655 | §101§103§112 | Non-Final OA | — | Pending | Aug 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialExsymol has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Robert Franklin Spaine has the most, with 1 of Exsymol's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
